Home

أنا آسف ملاحظة يحتوي diasorin in borsa Italy إلى الأسفل المحرك المؤشر

Our history | DiaSorin
Our history | DiaSorin

Medical Countermeasures | USA Public Health Security
Medical Countermeasures | USA Public Health Security

DiaSorin: Overvalued Italian Healthcare Company (OTCMKTS:DSRLF) | Seeking  Alpha
DiaSorin: Overvalued Italian Healthcare Company (OTCMKTS:DSRLF) | Seeking Alpha

Simplexa® SARS-CoV-2 Variants Direct (RUO) - DiaSorin Molecular
Simplexa® SARS-CoV-2 Variants Direct (RUO) - DiaSorin Molecular

Minnesota State College Southeast - News, Events, and Updates
Minnesota State College Southeast - News, Events, and Updates

DiaSorin Inc. | LinkedIn
DiaSorin Inc. | LinkedIn

DiaSorin announces the launch of a fully automated serology test to detect  antibodies against SARS-CoV-
DiaSorin announces the launch of a fully automated serology test to detect antibodies against SARS-CoV-

DiaSorin S.p.A. (DSRL.F) Company Information - Simply Wall St
DiaSorin S.p.A. (DSRL.F) Company Information - Simply Wall St

Annual Financial Report
Annual Financial Report

DiaSorin S.p.A. Completes Acquisition of the Focus Diagnostics' Molecular  and Immunoassay Product Business from Quest Diagnostics
DiaSorin S.p.A. Completes Acquisition of the Focus Diagnostics' Molecular and Immunoassay Product Business from Quest Diagnostics

DiaSorin - The Diagnostic Specialist
DiaSorin - The Diagnostic Specialist

Relazione_CG_Esercizio_31 12 2008_en
Relazione_CG_Esercizio_31 12 2008_en

About us | DiaSorin
About us | DiaSorin

Meet our People | DiaSorin
Meet our People | DiaSorin

Diasorin heads to the US with $1.8bn Luminex deal | Evaluate
Diasorin heads to the US with $1.8bn Luminex deal | Evaluate

DiaSorin buys out rival diagnostics firm Luminex for $1.8bn
DiaSorin buys out rival diagnostics firm Luminex for $1.8bn

DiaSorin S.p.A. : Shareholders Board Members Managers and Company Profile |  IT0003492391 | MarketScreener
DiaSorin S.p.A. : Shareholders Board Members Managers and Company Profile | IT0003492391 | MarketScreener

proudtobeDiaSorin | DiaSorin
proudtobeDiaSorin | DiaSorin

Borsa: Milano in calo (-0,45%), cede Diasorin, balza Mps - Notizie - Ansa.it
Borsa: Milano in calo (-0,45%), cede Diasorin, balza Mps - Notizie - Ansa.it

Italy's DiaSorin sees 60% plunge in COVID-19 revenue next year | Reuters
Italy's DiaSorin sees 60% plunge in COVID-19 revenue next year | Reuters

DiaSorin's LIAISON® SARS-CoV-2 Diagnostic Solutions | DiaSorin
DiaSorin's LIAISON® SARS-CoV-2 Diagnostic Solutions | DiaSorin

DiaSorin completes acquisition of Luminex - July 14, 2021 - YouTube
DiaSorin completes acquisition of Luminex - July 14, 2021 - YouTube

DiaSorin Italia S.p.A. | DiaSorin
DiaSorin Italia S.p.A. | DiaSorin

Press Release
Press Release

DiaSorin | LinkedIn
DiaSorin | LinkedIn

DiaSorin : Taking on board the near-term difficulties -August 16, 2023 at  05:46 am| MarketScreener
DiaSorin : Taking on board the near-term difficulties -August 16, 2023 at 05:46 am| MarketScreener

Diasorin Launches LIAISON IQ POC Reader with 10-Minute SARS-CoV-2 Antibody  Test - COVID-19 - mobile.Labmedica.com
Diasorin Launches LIAISON IQ POC Reader with 10-Minute SARS-CoV-2 Antibody Test - COVID-19 - mobile.Labmedica.com

Azioni Diasorin: Analisi Tecnica - Borsa Italiana
Azioni Diasorin: Analisi Tecnica - Borsa Italiana

Results | DiaSorin
Results | DiaSorin

DiaSorin - The Diagnostic Specialist
DiaSorin - The Diagnostic Specialist

DiaSorin, ricavi in calo nel primo semestre. +4% ex Covid
DiaSorin, ricavi in calo nel primo semestre. +4% ex Covid

DiaSorin | Saluggia
DiaSorin | Saluggia

DiaSorin | Saluggia
DiaSorin | Saluggia

DiaSorin - The Diagnostic Specialist
DiaSorin - The Diagnostic Specialist

Annual Financial Report
Annual Financial Report

COVID-19 | Updates | DiaSorin
COVID-19 | Updates | DiaSorin

DiaSorin - The Diagnostic Specialist
DiaSorin - The Diagnostic Specialist

DiaSorin | Saluggia
DiaSorin | Saluggia

DiaSorin simplifies diagnostics by implementing a digital solution | Reply
DiaSorin simplifies diagnostics by implementing a digital solution | Reply

Annual Financial Report
Annual Financial Report

Italian biotech company DiaSorin says its Covid-19 tests can detect omicron  variant
Italian biotech company DiaSorin says its Covid-19 tests can detect omicron variant

DiaSorin Molecular LLC | LinkedIn
DiaSorin Molecular LLC | LinkedIn

DiaSorin Completes $1.8bn Acquisition Of Luminex :: Medtech Insight
DiaSorin Completes $1.8bn Acquisition Of Luminex :: Medtech Insight

DIASORIN S.p.A. REPORT ON THE REMUNERATION POLICY AND FEES PAID 2020
DIASORIN S.p.A. REPORT ON THE REMUNERATION POLICY AND FEES PAID 2020